Department of Gastroenterology, Hospital General de Tomelloso

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE	Digestive System Diseases, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, digestive system disorder, eosinophilic esophagitis, esophageal disorder, esophagitis, gastroenteritis, hematologic disorder, immune system disorder, leukocyte disorder	Active, not recruiting	Phase 3	2026-08-28		NCT06596252

Clinical trials